What does PHARMACHIM do?

PHARMACHIM is a pharmacy in Seraing. Private Limited, started on 10 December 1999, 1 establishment.

What is the address of PHARMACHIM?

The registered office of PHARMACHIM is located at Rue de la Station 48, 4101 Seraing.

Is PHARMACHIM still active?

Yes. According to the CBE (28 September 2026) PHARMACHIM is active, legal situation “Normale toestand”, started on 10 December 1999.

Is PHARMACHIM registered on Peppol?

Yes, PHARMACHIM is registered on the Peppol network with ID 0208:0467190503.

What is the enterprise number of PHARMACHIM?

The enterprise number of PHARMACHIM is BE0467190503.

When was PHARMACHIM founded?

PHARMACHIM was founded on 10 December 1999.

Who are the directors of PHARMACHIM?

According to the 2025 annual accounts, the directors of PHARMACHIM are: Fabienne DAHOUT.

Is PHARMACHIM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 December 1999; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACHIM make in 2025?

PHARMACHIM posted a profit after taxes of € 53,894 in financial year 2025.

What is the revenue of PHARMACHIM?

As a small company, PHARMACHIM is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 303,200.

How much does an employee at PHARMACHIM earn?

The average wage cost per full-time employee at PHARMACHIM was € 67,600 in 2025: staff costs of € 189,169 for 2.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACHIM have?

According to the 2025 annual accounts, PHARMACHIM has 2.8 full-time equivalents (FTE).

PHARMACHIM (Private Limited) - Seraing - BE0467190503

Dossier PHARMACHIM, printed on 28 September 2026 from databakkes.be/en/0467190503/pharmachim. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACHIM from Seraing, company number BE0467190503, closed financial year 2025 with a result of € 53,894 after tax. For that financial year PHARMACHIM recorded a gross margin of € 303,200 and equity of € 295,335. Compared with financial year 2024, the result moved from € 75,739 to € 53,894. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 20, 2026.

What it is worth Growing

€ 295,335

▲ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 53,894

▼ 29% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 129,530

▼ 22% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 18,833 paid out

35 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

2.8

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 189,169

▲ 7% vs 2024

€ 67,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,437

▼ 39% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 268,499

▼ 14% vs 2024

€ 46,939 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 183,683

▲ 102% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 46,886

▲ 1% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 252,589 Gross margin 2022: € 252,589 First fiscal year in the series	€ 286,209 Gross margin 2023: € 286,209 ▲ 13% vs 2022 (€ 252,589) Favourable step	€ 329,580 Gross margin 2024: € 329,580 ▲ 15% vs 2023 (€ 286,209) Favourable step	€ 303,200 Gross margin 2025: € 303,200 ▼ 8% vs 2024 (€ 329,580) Unfavourable step	▼ 8%
Profit after taxes	€ 51,765 Profit after taxes 2022: € 51,765 First fiscal year in the series	€ 69,372 Profit after taxes 2023: € 69,372 ▲ 34% vs 2022 (€ 51,765) Favourable step	€ 75,739 Profit after taxes 2024: € 75,739 ▲ 9% vs 2023 (€ 69,372) Favourable step	€ 53,894 Profit after taxes 2025: € 53,894 ▼ 29% vs 2024 (€ 75,739) Unfavourable step	▼ 29%
Equity	€ 127,995 Equity 2022: € 127,995 First fiscal year in the series	€ 185,368 Equity 2023: € 185,368 ▲ 45% vs 2022 (€ 127,995) Favourable step	€ 260,274 Equity 2024: € 260,274 ▲ 40% vs 2023 (€ 185,368) Favourable step	€ 295,335 Equity 2025: € 295,335 ▲ 13% vs 2024 (€ 260,274) Favourable step	▲ 13%
Total debts	€ 546,162 Total debts 2022: € 546,162 First fiscal year in the series	€ 493,314 Total debts 2023: € 493,314 ▼ 10% vs 2022 (€ 546,162) Favourable step	€ 452,564 Total debts 2024: € 452,564 ▼ 8% vs 2023 (€ 493,314) Favourable step	€ 501,776 Total debts 2025: € 501,776 ▲ 11% vs 2024 (€ 452,564) Unfavourable step	▲ 11%
Cash	€ 159,013 Cash 2022: € 159,013 First fiscal year in the series	€ 137,508 Cash 2023: € 137,508 ▼ 14% vs 2022 (€ 159,013) Unfavourable step	€ 165,664 Cash 2024: € 165,664 ▲ 20% vs 2023 (€ 137,508) Favourable step	€ 129,530 Cash 2025: € 129,530 ▼ 22% vs 2024 (€ 165,664) Unfavourable step	▼ 22%
Land & buildings	€ 195,234 Land & buildings 2022: € 195,234 First fiscal year in the series	€ 180,644 Land & buildings 2023: € 180,644 ▼ 7% vs 2022 (€ 195,234) Unchanged	€ 166,054 Land & buildings 2024: € 166,054 ▼ 8% vs 2023 (€ 180,644) Unchanged	€ 151,464 Land & buildings 2025: € 151,464 ▼ 9% vs 2024 (€ 166,054) Unchanged	▼ 9%
Retained profit	€ 121,795 Retained profit 2022: € 121,795 First fiscal year in the series	€ 179,167 Retained profit 2023: € 179,167 ▲ 47% vs 2022 (€ 121,795) Favourable step	€ 254,073 Retained profit 2024: € 254,073 ▲ 42% vs 2023 (€ 179,167) Favourable step	€ 289,135 Retained profit 2025: € 289,135 ▲ 14% vs 2024 (€ 254,073) Favourable step	▲ 14%
Dividend	€ 26,000 Dividend 2022: € 26,000 First fiscal year in the series	€ 12,000 Dividend 2023: € 12,000 ▼ 54% vs 2022 (€ 26,000) Unchanged	€ 833 Dividend 2024: € 833 ▼ 93% vs 2023 (€ 12,000) Unchanged	€ 18,833 Dividend 2025: € 18,833 ▲ € 18,000 vs 2024 (€ 833) Unchanged	▲ € 18,000
Bank debt	€ 401,154 Bank debt 2022: € 401,154 First fiscal year in the series	€ 355,897 Bank debt 2023: € 355,897 ▼ 11% vs 2022 (€ 401,154) Favourable step	€ 313,100 Bank debt 2024: € 313,100 ▼ 12% vs 2023 (€ 355,897) Favourable step	€ 268,499 Bank debt 2025: € 268,499 ▼ 14% vs 2024 (€ 313,100) Favourable step	▼ 14%
Balance sheet total	€ 674,157 Balance sheet total 2022: € 674,157 First fiscal year in the series	€ 678,682 Balance sheet total 2023: € 678,682 ▲ 1% vs 2022 (€ 674,157) Unchanged	€ 712,838 Balance sheet total 2024: € 712,838 ▲ 5% vs 2023 (€ 678,682) Unchanged	€ 797,111 Balance sheet total 2025: € 797,111 ▲ 12% vs 2024 (€ 712,838) Unchanged	▲ 12%
Employees (FTE)	2.3 Employees (FTE) 2022: 2.3 First fiscal year in the series	2.6 Employees (FTE) 2023: 2.6 ▲ 0.3 vs 2022 (2.3) Unchanged	2.8 Employees (FTE) 2024: 2.8 ▲ 0.2 vs 2023 (2.6) Unchanged	2.8 Employees (FTE) 2025: 2.8 Unchanged (2.8) Unchanged

Key figures of PHARMACHIM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACHIM?

What happened at PHARMACHIM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 20, 2026 New annual accounts for financial year 2025: profit of € 53,894 (▼ 29% vs 2024). filed late Source: NBB ↗
Sep 25, 2000 New establishment in Seraing. KBO
Dec 10, 1999 Start of the company according to the CBE. KBO

In short

From € 51,765 profit in 2022 to € 53,894 profit in 2025.

Paid € 100,565 in corporate taxes since 2022.

Best year ever: 2024, with € 75,739 profit.

On average € 108,300 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACHIM? We notify you, reason included.

Follow PHARMACHIM

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Fabienne DAHOUT

PHARMACHIM

Behind PHARMACHIM is Fabienne DAHOUT.

See the full network in the app

Directors

According to the 2025 annual accounts

Fabienne DAHOUT

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Station 48

4101 Seraing

2.094.003.534

Rue de la Station 46

4101 Seraing

Active since 25 September 2000

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Association des copropriétaires de l'immeuble à Seraing ex Jemeppe, rue de la Station 48

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0467.190.503

VAT number

BE 0467.190.503

Registered office

Rue de la Station 48, 4101 Seraing

Names & denominations

PHARMACHIM

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

10 December 1999

Peppol

Active · Active since 28 Nov 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACHIM

Financials

What happened to PHARMACHIM?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions